
Wegovy Pill Side Effects: What's Different From the Injection
Wegovy pill side effects are mostly nausea, vomiting and diarrhea, similar to the shot. Trial rates, dysesthesia, levothyroxine and when to call a doctor.
Written by Diana Gangan. Updated November 8, 2026.
The most common Wegovy pill side effects are stomach and gut problems, mainly nausea, vomiting and diarrhea, and they are about as common as with the Wegovy injection. In the main trial of the 25 mg tablet, called OASIS 4, 46.6% of people taking the pill reported nausea and 30.9% reported vomiting, against 18.6% and 5.9% on a placebo (a dummy pill). Gastrointestinal (GI) side effects of any kind affected 74% of the pill group, close to the 73% seen with the 2.4 mg injection in its own trials. Those numbers come from different studies, so they cannot be compared head to head, but they do not suggest the pill is gentler on the stomach. The pill also has a few side-effect features of its own: there are no injection-site reactions, 5% of people in the trial reported changes in skin sensation (dysesthesia) against none on placebo, it raised levels of the thyroid medicine levothyroxine, and it must be taken by strict morning rules. About 7% of people stopped the pill because of side effects, roughly the same as with the injection. This guide sets out the numbers from the FDA label and the trial, what to watch for, and when to call your doctor.
Wegovy Pill Side Effects: The Short Answer
- 1Most common: nausea, vomiting, diarrhea, constipation, stomach pain and headache, mostly mild to moderate and most frequent during dose increases.
- 2How often: nausea 46.6% and vomiting 30.9% on the 25 mg pill in OASIS 4; any GI side effect 74% vs 42.2% on placebo.
- 3Versus the injection: headline GI rates are similar (nausea 44%, vomiting 24%, any GI 73% for the 2.4 mg shot), but the trials differ, so they are not directly comparable.
- 4Pill-specific points: no injection-site reactions, dysesthesia in 5% (vs 0% on placebo), and a 33% rise in levothyroxine exposure.
- 5Serious risks: the same boxed warning and warnings as the injection, including pancreatitis, gallbladder disease and severe GI reactions.
- 6Stopping for side effects: about 7% on the pill vs 5.9% on placebo; if 25 mg is not tolerated, the label says to consider the 1.7 mg injection.
What Are the Most Common Side Effects of the Wegovy Pill?
Wegovy tablets contain semaglutide, the same GLP-1 receptor agonist as the Wegovy pen. GLP-1 medicines slow the emptying of the stomach and act on appetite centers in the brain, which is why most of their side effects involve the gut. The Wegovy tablet and injection share one prescribing information document, revised in June 2026, and its Medication Guide lists the same most common side effects for both: nausea, diarrhea, vomiting, constipation, stomach pain, headache, tiredness, upset stomach, dizziness, bloating, belching, gas, heartburn, stomach flu, hair loss and changes in skin sensations.
For the pill specifically, the label says the types and frequency of common side effects in the tablet trial were similar to those in the injection trials. Endocrine News, summarizing OASIS 4, described the GI events as mainly nausea and diarrhea. Two of the listed effects have their own guides on this site: tiredness on Wegovy and hair loss on Wegovy.
How Often Do Wegovy Pill Side Effects Happen?
OASIS 4 randomized 307 adults with obesity or overweight to 25 mg oral semaglutide (205 people) or placebo (102 people) for 64 weeks; the results were published in the New England Journal of Medicine in September 2025. Some side effect was reported by 93.1% on the pill and 85.3% on placebo.
- 1Any GI side effect: 74.0% on the pill vs 42.2% on placebo.
- 2Nausea: 46.6% vs 18.6%.
- 3Vomiting: 30.9% vs 5.9%.
- 4Severe GI reactions: 2% vs 0%, according to the FDA label.
- 5Gallstones (cholelithiasis): 2.5% vs 1%.
- 6Dysesthesia: 5% vs 0%.
- 7Serious adverse events of any cause: 3.9% vs 8.8%.
Diarrhea, constipation, stomach pain, headache and belching also occurred in the trial, but we could not verify the pill-specific percentages for these against the full trial report or label table, so we have left the numbers out.
Is the Wegovy Pill Easier on the Stomach Than the Injection?
Not on current evidence. The table below puts the pill's trial numbers next to the injection's label numbers, each with its own placebo rate in brackets. The important caveat is that these come from different trials, run in different groups of people at different times, so the small gaps between them do not prove one form causes more or fewer side effects. A direct comparison would need a trial that gave people the pill or the injection at random, and none has been published. What the numbers do show is that switching to the pill is not a reliable way to avoid nausea.
Wegovy pill (OASIS 4, 25 mg) vs Wegovy injection (label Table 3, 2.4 mg); placebo rates in brackets. Different trials, not directly comparable.
Nausea
46.6% (18.6%)
44% (16%)
Vomiting
30.9% (5.9%)
24% (6%)
Any GI side effect
74% (42.2%)
73% (47%)
Stopped because of side effects
6.9% (5.9%)
6.8% (3.2%)
Injection-site reactions
No
Yes
Daily administration rules
Yes: empty stomach, up to 4 oz water, wait 30 minutes
No: once-weekly pen
Dysesthesia (skin sensation changes)
Yes: 5% (0%)
No comparable figure in the label summary
Price, convenience and weight loss are compared separately in our Wegovy pill vs injection guide. If you take a different oral semaglutide for diabetes, see our page on Rybelsus for weight loss.
When Do Wegovy Pill Side Effects Start, and How Long Do They Last?
GI side effects are most likely when you start and each time the dose goes up. The label raises the tablet dose every 30 days: 1.5 mg for days 1 to 30, 4 mg for days 31 to 60, 9 mg for days 61 to 90 and 25 mg from day 91 onward. This gradual climb exists to give the gut time to adjust. Among people in OASIS 4 who had nausea, it lasted 13 days on average, according to a Clinical Endocrinology News report of the trial.
If side effects are hard to manage during a dose step, talk to your prescriber rather than changing the schedule yourself. Our guides to the Wegovy dosing schedule and staying on a lower dose of Wegovy cover how prescribers handle slower escalation.
Can the Way You Take the Wegovy Pill Affect Side Effects?
The tablet has stricter rules than most pills because semaglutide is poorly absorbed from the gut and food or drink can reduce how much gets into the blood. According to the label:
- 1Take it in the morning on an empty stomach, with up to 4 oz (about half a cup) of plain water and no other liquids.
- 2Swallow one tablet whole each day; do not split, crush, chew or dissolve it.
- 3Wait at least 30 minutes before eating, drinking or taking other oral medicines.
- 4If you miss a dose, skip it and take the next dose the following day; do not double up.
No study we found shows that following these rules lowers side-effect rates. Their purpose is consistent absorption, so that you get a steady, predictable dose. That matters indirectly: erratic absorption makes it harder to tell whether a symptom is related to a dose change, and the 30-minute wait also affects how other morning medicines are absorbed, which is why the thyroid interaction below matters. The label summary we reviewed does not give separate advice for vomiting soon after a dose, so ask your pharmacist what to do if that happens.
What Is Dysesthesia, and Why Is It on the Wegovy Pill Label?
Dysesthesia means abnormal or unpleasant sensations on the skin, such as tingling, burning, prickling or sensitivity to touch, without an obvious cause. The Medication Guide describes it in plain terms as changes in skin sensations. In OASIS 4, 5% of people taking the 25 mg tablet reported it, against 0% on placebo, which is why it appears among the pill's listed side effects. The label does not explain why it occurs. If you notice new skin sensations that bother you, or numbness or weakness, tell your doctor so other causes can be checked.
What Serious Side Effects Should You Watch For on the Wegovy Pill?
The tablet carries the same boxed warning and warnings as the injection. A boxed warning is the FDA's strongest label warning. Wegovy should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC) or with multiple endocrine neoplasia syndrome type 2 (MEN 2). The label also warns that the risk of low blood sugar rises if Wegovy is used with insulin or sulfonylureas. What is known about longer-term risks is covered in our article on GLP-1 long-term side effects.
Serious risks on the Wegovy label (section 5 and Medication Guide)
Thyroid C-cell tumors (boxed warning)
Lump or swelling in the neck, trouble swallowing, hoarseness, shortness of breath
Tell your doctor promptly
Acute pancreatitis
Severe stomach pain that does not go away, sometimes spreading to the back, with or without vomiting
Stop the medicine and seek care right away
Gallbladder disease
Upper stomach pain, fever, yellow skin or eyes, clay-colored stools
Contact your doctor promptly
Low blood sugar
Shakiness, sweating, confusion, fast heartbeat, dizziness
Treat as advised; higher risk with insulin or sulfonylureas
Kidney injury from dehydration
Reduced urination, especially after vomiting or diarrhea
Drink fluids; contact your doctor if severe
Severe GI reactions
Persistent vomiting, diarrhea or stomach pain
Contact your doctor; 2% vs 0% in the tablet trial
Allergic reactions
Swelling of face, lips or throat, trouble breathing, severe rash
Seek emergency care
Diabetic retinopathy (type 2 diabetes)
Vision changes
Tell your doctor
Increased heart rate
Racing or pounding heartbeat at rest
Tell your doctor
Aspiration during anesthesia or sedation
Risk of stomach contents entering the lungs
Tell your care team you take Wegovy before any procedure
In the injection trials, acute pancreatitis occurred at 0.2 cases per 100 patient-years, against fewer than 0.1 on placebo. Vomiting and diarrhea also make dehydration more likely, and alcohol can add to that and to low blood sugar risk, as explained in Wegovy and alcohol.
Does the Wegovy Pill Interact With Thyroid Medication and Other Pills?
Yes, with levothyroxine. In a study reported on the label, taking the Wegovy tablet raised total thyroxine exposure (AUC, the total amount in the blood over time) by 33%. Levothyroxine is a narrow-therapeutic-index drug, meaning small changes in blood levels can matter, so the label advises monitoring such oral medicines. If you take levothyroxine, your doctor may want to recheck your thyroid levels after you start the pill. The label found no clinically significant changes with omeprazole, lisinopril, warfarin, metformin, digoxin, a combined oral contraceptive (ethinyl estradiol and levonorgestrel), furosemide or rosuvastatin. Because other oral medicines have to wait at least 30 minutes after the tablet, ask your pharmacist how to time your morning pills.
What If You Can't Tolerate the 25 mg Wegovy Pill?
The label offers a specific option: if the 25 mg tablet is not tolerated, consider switching to the 1.7 mg Wegovy injection. That is a decision for your prescriber, who can also consider whether you need more time at a lower step. Do not stop and restart on your own at a high dose, because restarting can bring back the side effects of the early weeks. If you are thinking of stopping altogether, read what happens when you stop Wegovy first.
How Many People Stop the Wegovy Pill Because of Side Effects?
In the tablet trial, 6.9% of people on the pill stopped because of side effects, against 5.9% on placebo, according to section 6 of the label; section 14 gives 6.8%, so about 7% is a fair summary. GI side effects caused 3.4% to stop, against 2% on placebo. Overall, fewer people stopped the pill for any reason (18%) than stopped placebo (25.5%). For the 2.4 mg injection, 6.8% stopped because of side effects against 3.2% on placebo.
When to Talk to Your Doctor
- 1Severe stomach pain that does not go away, with or without vomiting.
- 2Vomiting or diarrhea that stops you keeping fluids down, or signs of dehydration such as little urine.
- 3Pain in the upper right stomach, fever, or yellowing of the skin or eyes.
- 4A lump in the neck, trouble swallowing or persistent hoarseness.
- 5Swelling of the face or throat, or trouble breathing: seek emergency care.
- 6New skin sensations that are troublesome, or vision changes if you have type 2 diabetes.
- 7Nausea that is still severe weeks after a dose increase.
Questions to Ask Your Doctor Before Starting the Wegovy Pill
- 1Is the pill or the injection a better fit for my other medicines and my morning routine?
- 2I take levothyroxine: when should my thyroid levels be rechecked?
- 3How should I time my other morning medicines around the 30-minute wait?
- 4What should I do if I vomit soon after taking a dose?
- 5If side effects are hard at a dose step, can I stay at that step longer?
- 6If I can't tolerate 25 mg, would the 1.7 mg injection be an option for me?
- 7Do I need my diabetes medicines adjusted to lower the risk of low blood sugar?
Many pill side effects are easier to manage when the tablet is taken the right way. Our step-by-step guide on how to take the Wegovy pill covers the empty-stomach rule, how much water to use and how long to wait before eating.
The Bottom Line
Wegovy pill side effects are largely the same as the injection's: mostly nausea, vomiting and other GI symptoms, worst during dose increases and usually easing with time. The headline rates in the pill's trial were as high as or slightly higher than the injection's, but they come from different trials and cannot be compared directly. The pill removes injection-site reactions but adds strict daily rules, a levothyroxine interaction and a 5% rate of skin-sensation changes. About 7% stop because of side effects, and if 25 mg is too much, the label points to the 1.7 mg injection as an alternative. As of November 2026, discuss any persistent or severe symptoms with your prescriber.
FAQ
Not on current evidence. Nausea affected 46.6% on the 25 mg pill in OASIS 4 and 44% on the 2.4 mg injection in its trials. The trials were different, so the figures are not directly comparable, but the pill does not appear gentler.
Among people in OASIS 4 who had nausea, it lasted 13 days on average. It is most likely when starting and after each dose increase.
Food can reduce how much semaglutide is absorbed, which can make your dose less consistent. The label says to wait at least 30 minutes before eating, drinking or taking other oral medicines.
No. Take the tablet with up to 4 oz of plain water only, then wait at least 30 minutes before having coffee or any other drink.
Hair loss is listed in the Medication Guide among the common side effects for Wegovy. For what is known about it, see our guide to Wegovy and hair loss.
Yes. The tablet raised total thyroxine exposure by 33% in a label study, and the label advises monitoring. Ask your doctor whether to recheck your thyroid levels.
Sources
- 1Novo Nordisk. Wegovy (semaglutide) tablets and injection: Prescribing Information and Medication Guide, revised 06/2026, US Food and Drug Administration, 2026
- 2US Food and Drug Administration. NDA 218316 approval letter, Wegovy tablets, FDA, 2025
- 3Wharton S et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4), New England Journal of Medicine, 2025
- 4Wharton S et al. OASIS 4 abstract, New England Journal of Medicine, 2025
- 5Novo Nordisk. Oral semaglutide 25 mg delivered 16.6% weight loss (release republished), Drugs.com, 2025
- 6Novo Nordisk. Wegovy pill approved in the US as first oral GLP-1 for weight management, BioSpace, 2025
- 7Oral semaglutide 25 mg dose may provide most benefit, Clinical Endocrinology News, 2025
- 8Novo Nordisk's OASIS 4 study validates daily oral pill for chronic weight management, Endocrine News, 2026
- 9Novo Nordisk Wegovy pill becomes first oral GLP-1 available in the US, Pharmaceutical Executive, 2026
This article summarizes the FDA label and published research for general information and is not medical advice. The OASIS 4 and STEP trials were funded by Novo Nordisk, the maker of Wegovy.

Diana Gangan
Author
Comments (0)
Be the first to comment on this article.




